Literature DB >> 20571255

Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications.

Nerea Maiz1, Kypros H Nicolaides.   

Abstract

In the first trimester the ductus venosus can be easily identified with color Doppler and a ductus venosus waveform can be obtained by pulsed Doppler. At 11-13 weeks the prevalence of abnormal a-wave in the ductus venosus is inversely related to fetal crown-rump length and maternal serum pregnancy-associated plasma protein-A (PAPP-A), increases with fetal nuchal translucency (NT) thickness and is more common in women of Black racial origin and in fetuses with abnormal karyotype or cardiac defects. Ductus venosus flow provides an independent contribution in the prediction of chromosomal abnormalities when combined with NT and the maternal serum markers of PAPP-A and free beta-hCG, increasing the detection rate to 96% at a false-positive rate of 2.6%. Abnormal ductus venosus flow increases the risk of cardiac defects in fetuses with NT above the 95th centile, and it may increase the risk in fetuses with normal NT. In twin pregnancies, abnormal ductus venosus flow is associated with chromosomal abnormalities and cardiac defects. In monochorionic twins, abnormal flow in the ductus venosus in at least 1 of the fetuses increases the risk of developing twin-to-twin transfusion syndrome. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20571255     DOI: 10.1159/000314036

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

Review 1.  Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function.

Authors:  Joana O Miranda; Carla Ramalho; Tiago Henriques-Coelho; José Carlos Areias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Doppler assessment of the ductus venosus and the tricuspid valve at 11-13+6 weeks: Reference ranges and development of sonographic quality assurance standards.

Authors:  Vanessa Pincham; Jon Hyett; Karen Pollard; Philip Schluter; Andrew McLennan
Journal:  Australas J Ultrasound Med       Date:  2016-02-21

Review 3.  Prenatal screening for structural congenital heart disease.

Authors:  Lindsey E Hunter; John M Simpson
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

4.  Retrospective validation of 11-13 weeks' gestation ultrasound characteristics as predictive tools for twin-twin transfusion syndrome and selective intrauterine growth restriction in monochorionic diamniotic twin pregnancies.

Authors:  Yin-Di Zhu; Jin-Yan Bian; Yu-Ping Liao; Ting Hu; Ming-Yue Wang; You-Guo Chen; Mei-Fang Pan; Xin-Xian Gu
Journal:  Ann Transl Med       Date:  2021-09

Review 5.  Prenatal Screening Using Maternal Markers.

Authors:  Howard Cuckle
Journal:  J Clin Med       Date:  2014-05-09       Impact factor: 4.241

Review 6.  EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Prenatal diagnosis of congenital heart disease.

Authors:  Lindsey E Hunter; Anna N Seale
Journal:  Echo Res Pract       Date:  2018-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.